May 20, 2015

The gummy sub-segment within overall vitamins is not only still growing substantially, the dollar volume of that alternative delivery format has reached nowhere near its ceiling of potential, at least not yet. Overall, sales of vitamins for the 52 weeks ended Dec. 28, 2014, were up 0.4% to $6.5 billion across total U.S. multi-outlets, according to IRI.

May 20, 2015

Perrigo Animal Health in May announced its launch of PetArmor Joint Health Maximum, a supplement for dogs that contains glucosamine, chondroitin, MSM and manganese. It’s an opportunity for retailer’s to associate their store brand with a quality pet supplement.

May 12, 2015

Perrigo enhances softgel production with latest acquisition. 

May 6, 2015

Perrigo Animal Health introduces CosequinDS national brand equivalent in Walmart. 

April 24, 2015

Mylan has announced that it will commence with a formal offer to acquire generic drug maker Perrigo.

April 22, 2015

Perrigo on Tuesday rejected a proposed acquisition by Mylan. 

April 22, 2015

Following Perrigo's rejection of a Mylan offer, Teva moves forward with its proposed acquistion of Mylan. 

April 21, 2015

Teva Pharmaceutical on Tuesday made a move for Mylan in a $40 billion deal barring Mylan's proposed acquisition of Perrigo. 

April 8, 2015

Mylan on Wednesday announced a proposal to acquire Perrigo in $29 billion deal. 

February 10, 2015

The Generic Pharmaceutical Association on Monday announced the election of its 2015 executive committee and board of directors.

January 12, 2015

Perrigo and Ferrara Candy Co. announced Monday that Perrigo's Nutritionals division has signed a supply agreement with Ferrara to manufacture store brand gummy vitamins and dietary supplements.

January 12, 2015

Perrigo on Monday announced that it has launched clobetasol propionate spray, 0.05%, the generic equivalent to Clobex spray, 0.05%. 

January 12, 2015

Perrigo Co. on Monday announced the launch of testosterone gel 1%, the therapeutic equivalent to Androgel 1% from AbbVie. 

December 2, 2014

Perrigo on Tuesday announced that it has received final approval from the Food and Drug Administration on its abbreviated new drug application for diclofenac sodium topical solution 1.5% w/w.

November 24, 2014

Perrigo on Monday announced that it has agreed to market the authorized generic version of Astellas U.S.' Protopic ointment 0.1% and 0.03%. 

November 19, 2014

7‑Eleven, which has long offered single-dose blister packs of the most popular, national brand over-the-counter medications, on Tuesday entered the private-label drug business.

November 7, 2014

It's one month into the cough-cold season and illness rates are up 3%, noted Matthew Mannelly, Prestige Brands president and CEO.

November 7, 2014

Perrigo may one day expand into the branded side of the U.S. OTC business, Joseph Papa, Perrigo president, chairman and CEO, told analysts Thursday morning.

November 6, 2014

Perrigo and Omega Pharma announced that they have entered into a definitive agreement in which Perrigo has agreed to acquire Omega for $4.5 billion.

November 6, 2014

Perrigo on Thursday announced that it has reinitiated shipments of Guaifenesin 600mg Extended-Release tablets to its retail and wholesale customers in the United States.

July 30, 2014

Perrigo on Wednesday announced that it has filed an abbreviated new drug application with the Food and Drug Administration for desoximetasone topical spray 0.25%. The company also has notified Taro Pharmaceuticals U.S.A., the owner of the reference listed drug, of the filing.

June 20, 2014

Teva has reached a settlement with Perrigo Pharmaceutical and Catalent Pharma Solutions with respect to four patents for Teva’s ProAir HFA (albuterol sulfate) Inhalation aerosol product.

May 12, 2014

Perrigo on Monday announced that it received approval from the Food and Drug Administration for azelastine hydrochloride nasal spray (0.15%), a generic version of Astepro. The drug is indicated for people ages 12 years and older and is used to treat nasal symptoms brought on by seasonal allergies or environmental irritants.